Propel Bio Management

Propel Bio Management as of March 31, 2025

Portfolio Holdings for Propel Bio Management

Propel Bio Management holds 18 positions in its portfolio as reported in the March 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Plains Gp Holdings Lp-cl Comm (PAGP) 31.6 $27M 1.3M 21.36
Madrigal Pharmaceuticals Comm (MDGL) 11.6 $9.9M 30k 331.23
Akero Therapeutics Comm (AKRO) 10.8 $9.3M 229k 40.48
Phathom Pharmaceuticals I Comm (PHAT) 8.3 $7.1M 1.1M 6.27
Achieve Life Sciences Comm (ACHV) 7.6 $6.5M 2.5M 2.67
Applied Therapeutics Comm 6.4 $5.5M 11M 0.49
Avidity Biosciences Comm 6.1 $5.3M 179k 29.52
Abeona Therapeutics Comm (ABEO) 3.5 $3.0M 624k 4.76
Tscan Therapeutics Comm (TCRX) 3.3 $2.9M 2.1M 1.38
Delcath Systems Comm (DCTH) 2.6 $2.3M 178k 12.73
Syndax Pharmaceuticals In Comm (SNDX) 2.6 $2.3M 183k 12.29
Zevra Therapeutics Comm (ZVRA) 1.6 $1.3M 180k 7.49
Milestone Pharmaceuticals Comm (MIST) 1.3 $1.2M 1.5M 0.80
Maat Pharma Saca Comm (MATPF) 1.2 $1.0M 166k 6.24
Compass Therapeutics Comm (CMPX) 0.5 $434k 228k 1.90
Athira Pharma Comm (ATHA) 0.5 $425k 1.5M 0.28
Eiger Biopharmaceuticals Comm 0.5 $423k 146k 2.89
Chinook Therapeutics Comm 0.0 $39k 79k 0.49